Niki BioSolutions annual capital expenditures (capex)
2017
2018
2019
2020
2021
2022
2023
Niki BioSolutions Capital Expenditures (CapEx) Growth & History (NIKI)
Niki BioSolutions's capital expenditures (capex) was $3,015 for fiscal 2023.
View full Niki BioSolutions company overviewNiki BioSolutions annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2023 | 2023-12-31 | $3,015 | −$183,901 | −98.39% |
| 2022 | 2022-12-31 | $186,916 | $55,166 | +41.87% |
| 2021 | 2021-12-31 | $131,750 | −$29,564 | −18.33% |
| 2020 | 2020-12-31 | $161,314 | −$675,748 | −80.73% |
| 2019 | 2019-12-31 | $837,062 | −$4.8M | −85.18% |
| 2018 | 2018-12-31 | $5.6M | $3.6M | +170.07% |
| 2017 | 2017-12-31 | $2.1M | — | — |
Niki BioSolutions capital expenditures (capex) trends
Over the last five fiscal years, Niki BioSolutions's capital expenditures (capex) decreased from $5.6M to $3,015, a change of −$5.6M.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Niki BioSolutions source filings ↗